Literature DB >> 9014840

Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture.

Y H Abdel-Wahab1, F P O'Harte, C R Barnett, P R Flatt.   

Abstract

Characteristics of cellular insulin glycation were examined in the pancreatic B-cell line, BRIN-BD11. The extent of insulin glycation increased stepwise during 72 h of culture at 5.6-33.3 mmol/l glucose, attaining levels up to 27%. Glycation of insulin at 33.3 mmol/l glucose was rapid, reaching maximal values within 2 h, and not readily reversible during 2 to 24 h of subsequent exposure to 5.6 mmol/l glucose. Glycated insulin was readily secreted by BRIN-BD11 cells upon active stimulation with glucose and other secretagogues. Cellular insulin glycation was decreased by 66-80% by inhibitors of protein glycation, vitamin C, aminoguanidine or acetylsalicylic acid. Modulation of insulin-secretory activity of BRIN-BD11 cells by co-culture at high glucose with diazoxide. L-alanine or glibenclamide indicated that long-term stimulation of secretion was associated with a decrease in the extent of insulin glycation. Glycation of insulin in vitro was substantially less extensive than in BRIN-BD11 cells, although glucose-6-phosphate and glyceraldehyde-3-phosphate were 1.4- to 2.0-fold more reactive than glucose per se. These observations indicate that insulin is readily glycated and secreted from insulin-secreting cells under hyperglycaemic conditions in culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9014840     DOI: 10.1677/joe.0.1520059

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  Insulin facilitates corneal wound healing in the diabetic environment through the RTK-PI3K/Akt/mTOR axis in vitro.

Authors:  C Peterson; H L Chandler
Journal:  Mol Cell Endocrinol       Date:  2022-02-26       Impact factor: 4.369

2.  Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassay.

Authors:  J R Lindsay; A M McKillop; M H Mooney; F P M O'Harte; P M Bell; P R Flatt
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

3.  Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry.

Authors:  Sofia Guedes; Rui Vitorino; M Rosário M Domingues; Francisco Amado; Pedro Domingues
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-13       Impact factor: 3.109

4.  Glucose binds to the insulin receptor affecting the mutual affinity of insulin and its receptor.

Authors:  Robert Root-Bernstein; Jessica Vonck
Journal:  Cell Mol Life Sci       Date:  2009-06-25       Impact factor: 9.261

5.  The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.

Authors:  Viraj R Sanghvi; Josef Leibold; Marco Mina; Prathibha Mohan; Marjan Berishaj; Zhuoning Li; Matthew M Miele; Nathalie Lailler; Chunying Zhao; Elisa de Stanchina; Agnes Viale; Leila Akkari; Scott W Lowe; Giovanni Ciriello; Ronald C Hendrickson; Hans-Guido Wendel
Journal:  Cell       Date:  2019-08-08       Impact factor: 66.850

Review 6.  Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.

Authors:  Kerstin Nowotny; Tobias Jung; Annika Höhn; Daniela Weber; Tilman Grune
Journal:  Biomolecules       Date:  2015-03-16

7.  Alterations in Concentration/Activity of Superoxide Dismutases in Context of Obesity and Selected Single Nucleotide Polymorphisms in Genes: SOD1, SOD2, SOD3.

Authors:  Łukasz Lewandowski; Marta Kepinska; Halina Milnerowicz
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

Review 8.  The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Authors:  Narasimha M Beeraka; Venugopal R Bovilla; Shalini H Doreswamy; Sujatha Puttalingaiah; Asha Srinivasan; SubbaRao V Madhunapantula
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

9.  An insulin-like modular basis for the evolution of glucose transporters (GLUT) with implications for diabetes.

Authors:  Robert Root-Bernstein
Journal:  Evol Bioinform Online       Date:  2007-10-15       Impact factor: 1.625

Review 10.  Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity.

Authors:  Yoshimitsu Kiriyama; Hiromi Nochi
Journal:  Cells       Date:  2018-08-06       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.